Guoji Yanke Zazhi (Dec 2013)

Clinical study on the optic nerve protection of calcium dobesilate in treating glaucoma

  • Yan-Ni Zhu,
  • Yan-Jie Bai,
  • Yan-Hua Zhu,
  • Jia-Hua Fang,
  • Zu-Hai Zhang

DOI
https://doi.org/10.3980/j.issn.1672-5123.2013.12.28
Journal volume & issue
Vol. 13, no. 12
pp. 2459 – 2461

Abstract

Read online

AIM:To observe the protective effect of calcium dobesilate on optic nerve of glaucoma patients whose intraocular pressure has been under control through operation.METHODS: A total of 78 inpatients(89 eyes)with glaucoma in this hospital from January, 2011 to February, 2012 were enrolled. All patients were randomly divided into treatment group and control group with 6 months in a course. The visual acuity, visual field(mean sensibility, MS), and intraocular pressure were measured at the experiment onset and 6 months later to evaluate the clinical effect.RESULTS: There were no statistically significant differences in the visual acuity, intraocular pressure between the two groups neither at the experiment onset nor after 6 months(P>0.05). The mean sensibility(MS)of the treatment group was obviously improved(14.56±5.03 vs 18.9±5.77, Pvs 13.48±4.69). There are statistically significant difference between the treatment group and the control group. Compared to the ratio of improvement, stability, and deterioration in the control group(10.3%, 48.7%, 41.0%), the indexes were changed obviously in the treatment group(64.1%, 28.2%, 7.7%,PCONCLUSION:Calcium dobesilate can improve mean retinal sensitivity and protect the optic nerve in glaucoma patients whose intraocular pressure has been controlled.

Keywords